PACAP has been identified in the hypothalamo–hypophyseal system [1] and its protective role has been shown in several pathological CNS disorders, such as ischemia [43], spinal cord injury [44], inflammation [45], peripheral nerve regeneration [46] and retinopathy [47]. Here, ADCYAP1 is linked to central nervous system disorder.